These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 2786089)

  • 1. Oligomeric structure of gp41, the transmembrane protein of human immunodeficiency virus type 1.
    Pinter A; Honnen WJ; Tilley SA; Bona C; Zaghouani H; Gorny MK; Zolla-Pazner S
    J Virol; 1989 Jun; 63(6):2674-9. PubMed ID: 2786089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Humoral response to oligomeric human immunodeficiency virus type 1 envelope protein.
    Richardson TM; Stryjewski BL; Broder CC; Hoxie JA; Mascola JR; Earl PL; Doms RW
    J Virol; 1996 Feb; 70(2):753-62. PubMed ID: 8551612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenic implications of human immunodeficiency virus type 1 envelope quaternary structure: oligomer-specific and -sensitive monoclonal antibodies.
    Broder CC; Earl PL; Long D; Abedon ST; Moss B; Doms RW
    Proc Natl Acad Sci U S A; 1994 Nov; 91(24):11699-703. PubMed ID: 7972127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Native oligomeric human immunodeficiency virus type 1 envelope glycoprotein elicits diverse monoclonal antibody reactivities.
    Earl PL; Broder CC; Long D; Lee SA; Peterson J; Chakrabarti S; Doms RW; Moss B
    J Virol; 1994 May; 68(5):3015-26. PubMed ID: 7512157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fine mapping of an immunodominant region of the transmembrane protein of the human immunodeficiency virus (HIV-1).
    Döpel SH; Porstmann T; Henklein P; von Baehr R
    J Virol Methods; 1989 Aug; 25(2):167-77. PubMed ID: 2476460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibodies to gp110 and gp41 of human immunodeficiency virus.
    Gosting LH; McClure J; Dickinson ES; Watanabe SM; Shriver K; Goldstein LC
    J Clin Microbiol; 1987 May; 25(5):845-8. PubMed ID: 2438302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human monoclonal antibody 98-6 reacts with the fusogenic form of gp41.
    Taniguchi Y; Zolla-Pazner S; Xu Y; Zhang X; Takeda S; Hattori T
    Virology; 2000 Aug; 273(2):333-40. PubMed ID: 10915604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial purification of native HIV transmembrane protein gp41: generation of polyclonal and monoclonal antibodies.
    Zweig M; Showalter SD; Bladen SV; Gilden RV; Arthur LO; Robey WG; Nara PL; Fischinger PJ
    AIDS Res Hum Retroviruses; 1988 Feb; 4(1):51-62. PubMed ID: 3259140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic env gp41 peptide as a sensitive and specific diagnostic reagent in different stages of human immunodeficiency virus type 1 infection.
    Närvänen A; Korkolainen M; Suni J; Korpela J; Kontio S; Partanen P; Vaheri A; Huhtala ML
    J Med Virol; 1988 Oct; 26(2):111-8. PubMed ID: 2460585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nature of nonfunctional envelope proteins on the surface of human immunodeficiency virus type 1.
    Moore PL; Crooks ET; Porter L; Zhu P; Cayanan CS; Grise H; Corcoran P; Zwick MB; Franti M; Morris L; Roux KH; Burton DR; Binley JM
    J Virol; 2006 Mar; 80(5):2515-28. PubMed ID: 16474158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Administration of noninternal image monoclonal anti-idiotypic antibodies induces idiotype-restricted responses specific for human immunodeficiency virus envelope glycoprotein epitopes.
    Zhou EM; Lohman KL; Kennedy RC
    Virology; 1990 Jan; 174(1):9-17. PubMed ID: 1688476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a novel human immunodeficiency virus type 1 neutralizable epitope within the immunodominant region of gp41.
    Viveros M; Dickey C; Cotropia JP; Gevorkian G; Larralde C; Broliden K; Levi M; Burgess A; Cao C; Weiner DB; Agadjanyan MG; Ugen KE
    Virology; 2000 Apr; 270(1):135-45. PubMed ID: 10772986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of monoclonal antibodies to human immunodeficiency virus type 1 gp41 by HIV-1 polypeptides expressed in Escherichia coli.
    Larcher C; Bröker M; Huemer HP; Sölder B; Schulz TF; Hofbauer JM; Wachter H; Dierich MP
    FEMS Microbiol Immunol; 1990 Sep; 2(2):103-10. PubMed ID: 1701654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of gp41 antigens by enzyme-linked immunosorbent assays for detecting antibodies to human immunodeficiency virus type 1.
    Zweig M; Bladen SV; Dubois GC; Samuel KP; Showalter SD; Papas TS
    AIDS Res Hum Retroviruses; 1988 Dec; 4(6):487-92. PubMed ID: 3265329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the I559P gp41 change on the conformation and function of the human immunodeficiency virus (HIV-1) membrane envelope glycoprotein trimer.
    Alsahafi N; Debbeche O; Sodroski J; Finzi A
    PLoS One; 2015; 10(4):e0122111. PubMed ID: 25849367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutralization of diverse HIV-1 strains by monoclonal antibodies raised against a gp41 synthetic peptide.
    Dalgleish AG; Chanh TC; Kennedy RC; Kanda P; Clapham PR; Weiss RA
    Virology; 1988 Jul; 165(1):209-15. PubMed ID: 2838959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B cell epitope mapping of human immunodeficiency virus envelope glycoproteins with long (19- to 36-residue) synthetic peptides.
    Neurath AR; Strick N; Lee ES
    J Gen Virol; 1990 Jan; 71 ( Pt 1)():85-95. PubMed ID: 1689372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional role of the glycan cluster of the human immunodeficiency virus type 1 transmembrane glycoprotein (gp41) ectodomain.
    Fenouillet E; Jones I; Powell B; Schmitt D; Kieny MP; Gluckman JC
    J Virol; 1993 Jan; 67(1):150-60. PubMed ID: 8093218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Uncleaved and Mature Human Immunodeficiency Virus Membrane Envelope Glycoprotein Trimers.
    Castillo-Menendez LR; Witt K; Espy N; Princiotto A; Madani N; Pacheco B; Finzi A; Sodroski J
    J Virol; 2018 Jun; 92(12):. PubMed ID: 29618643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancing exposure of HIV-1 neutralization epitopes through mutations in gp41.
    Blish CA; Nguyen MA; Overbaugh J
    PLoS Med; 2008 Jan; 5(1):e9. PubMed ID: 18177204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.